S.African scientist: data show J&J vaccine works well against Delta variant

PUBLISHED: Fri, 02 Jul 2021 06:13:34 GMT

JOHANNESBURG, July 2 (Reuters) – Data from laboratory studies show Johnson & Johnson’s COVID-19 vaccine works well against the Delta variant that now dominates new infections in South Africa, the head of the country’s Medical Research Council said on Friday.

“All the data that we see indicate good immediate and sustained immune response against Delta, and we see surprising durability in the immune response for the single dose J&J right up to eight months,” Glenda Gray told a news conference.

South Africa is using the J&J and Pfizer vaccines in its immunisation campaign. (Reporting by Alexander Winning and Wendell Roelf; editing by Olivia Kumwenda-Mtambo)

(c) Copyright Thomson Reuters 2021. Click For Restrictions – https://agency.reuters.com/en/copyright.html

Sign Up for Our Newsletter Daily Update

Get the best of CNBC Africa sent straight to your inbox with breaking business news, insights and updates from experts across the continent.
Get this delivered to your inbox, and more info about about our products and services. By signing up for newsletters, you are agreeing to our Terms of Use and Privacy Policy.